Integrated Diagnostics Holdings plc
IDGXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.07 |
| FCF Yield | 1.41% | 1.20% | 3.74% | 4.53% |
| EV / EBITDA | 18.68 | 22.07 | 28.45 | 23.60 |
| Quality | ||||
| ROIC | 5.05% | 5.05% | 5.04% | 5.04% |
| Gross Margin | 42.04% | 42.04% | 39.00% | 39.00% |
| Cash Conversion Ratio | 0.71 | 0.71 | 2.04 | 2.04 |
| Growth | ||||
| Revenue 3-Year CAGR | 24.29% | 23.69% | 16.63% | 6.73% |
| Free Cash Flow Growth | 0.00% | -71.13% | 0.00% | 50.24% |
| Safety | ||||
| Net Debt / EBITDA | 0.11 | 0.11 | 0.61 | 0.61 |
| Interest Coverage | 0.00 | 0.00 | 370.27 | 370.27 |
| Efficiency | ||||
| Inventory Turnover | 2.78 | 2.78 | 3.09 | 3.09 |
| Cash Conversion Cycle | 55.39 | 55.39 | 45.36 | 45.36 |